Rodman & Renshaw upgrades Viropharma (Nasdaq: VPHM) from Market Perform to Market Outperform. Price target $18.

Rodman analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE